Lenalidomide

Revlimid

Thalidomide Analog

NADAC/unit N/A

No Shortage Tier 1: 114.9% PA Req: 621.9% 18 Manufacturers 110 ANDAs

Lenalidomide is a thalidomide analogue indicated for the treatment of adult patients with: Multiple myeloma (MM), in combination with dexamethasone ( 1.1 ).

Covered Lives

Generic Manufacturers

ACCORD HEALTHCARE INCALVOGEN INCAMNEAL EU LTDAPOTEX INCARROW INTERNATIONAL LTDBIOCON PHARMA LTDBRISTOL MYERS SQUIBBCIPLA LTDDEVA HOLDING ASDR REDDYS LABORATORIES LTDEUGIA PHARMA SPECIALITIES LTDHETERO LABS LTD UNIT VLUPIN LTDMYLAN PHARMACEUTICALS INCNOVUGEN ONCOLOGY SDN BHDQILU PHARMACEUTICAL CO LTDSUN PHARMACEUTICAL INDUSTRIES LTDTORRENT PHARMACEUTICALS LTDZYDUS PHARMACEUTICALS USA INC

Explore in the Ecosystem

rxsaver.aiCompare prices for Lenalidomide drfinder.aiFind doctors who prescribe Lenalidomide rxbenefits.aiEmployer cost impact analysis clinicalrx.aiClinical profile: Lenalidomide

Data sourced from CMS NADAC, FDA Orange Book, CMS Part D Formulary, CMS Part D Spending, openFDA, and HRSA 340B OPAIS. Prices reflect National Average Drug Acquisition Cost and may not represent actual transaction prices. This information is for research and comparison purposes only. Consult your pharmacist or benefits consultant for plan-specific pricing.